Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-22-011784
Filing Date
2022-05-02
Accepted
2022-05-02 16:05:37
Documents
14
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 399211
2 ex31-3.htm EX-31.3 5852
3 ex31-4.htm EX-31.4 6113
  Complete submission text file 0001493152-22-011784.txt   677991

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ocx-20211231.xsd EX-101.SCH 3030
5 XBRL LABEL FILE ocx-20211231_lab.xml EX-101.LAB 36496
6 XBRL PRESENTATION FILE ocx-20211231_pre.xml EX-101.PRE 23997
8 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 6836
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37648 | Film No.: 22881894
SIC: 2835 In Vitro & In Vivo Diagnostic Substances